Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers
- PMID: 22534620
- PMCID: PMC4538946
- DOI: 10.1161/CIRCULATIONAHA.112.107797
Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers
Conflict of interest statement
The author has no conflict of interest relevant to this manuscript.
Comment on
-
Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure.Circulation. 2012 Jun 5;125(22):2739-50. doi: 10.1161/CIRCULATIONAHA.111.047316. Epub 2012 Apr 25. Circulation. 2012. PMID: 22534621
References
-
- Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, Hannun YA, Obeid LM. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem. 2001;276:35258–35264. - PubMed
-
- Torre-Amione G, Kapadia S, Benedict CR, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD) J Am Coll Cardiol. 1996;27:1201–1206. - PubMed
-
- Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro. Am J Physiol. 1995;37:H517–H525. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
